Tom Li

Tom Li

Company: Burning Rock Biotech

Job title: Head of Global Biopharma Business Development


Global Trials – Benefits of Utilizing a Single Assay Worldwide 2:30 pm

Global Trials – Strategy and Challenges Single assay worldwide – Regulatory considerations, benefits, and considerations Burning Rock Oncoscreen – Widely used, well validated assay, (SEQC2- Nature, April 2021) easily deployable around the world.Read more

day: Track C - Day 1 PM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.